Key Financials
 
Key financials

Selected Key Figures*

The fiscal year of HELLA ends on May 31.

* Please observe the remarks on the Yearly Figures.

02/05/2016
Sales
EBITDA
EBIT
Earning
Net financial dept
Equity

Yearly figures

in € million 2016/2017 2015/2016 2014/2015
Sales 6,585 6,352 5,835
Change compared to previous period
[curency- and portfolio adjusted]
4% [4%] 9% [8%] 9% [7%]
EBIT [adjusted] 507 [534] 420 [476] 430 [445]
Change compared to previous period 21% [12%] -2% [7%] 24% [12%]
EBITDA [adjusted] 919 [946] 816 [858] 766 [781]
Change compared to previous period  13% [10%] 7% [10%] 17% [10%]
Earning for the period 343 272 295
Change compared to previous period  26% -8% 29%
Earnings per share (in €) 3.08 2.42 2.70
Change compared to previous period  27% -11% 21%
R&D expenses 636 623 544
Change compared to previous period 2% 15% 6%
Free Cashflow [adjusted] 69 [149] 76 [155] 142 [158]
Net capital expediture 517 463 347
       
EBIT margin [adjusted] 7.7% [8.1%] 6.6% [7.5%] 7.4% [7.6%]
EBITDA margin [adjusted] 14.0% [14.4%] 12.8% [13.5%] 13.1% [13.4%]
R&D expenses in relation to sales 9.7% 9.8% 9.3%
Net financial debt 278 238 131
Net financial debt/EBITDA (last 12 months) 0.3x 0.3x 0.2x
Equity ratio 39.5% 39.6% 38.8%
Return on equity (last 12 months) 17.3% 14.2% 22.0%
Number of employees (headcount) 37,716 33,689 31,864

 

For further informations, please refer to the Consolidated Financial Statement

08/10/2017
 
 

Nine Month Figures

in € million 9 Months
FY 2017/2018
9 Months
FY 2016/2017
Sales 5,130 4,776
Change compared to previous period
[curency- and portfolio adjusted]
7% [9%] 3% [3%]
EBIT [adjusted] 404 [408] 348 [373]
Change compared to previous period 16% [9%] 20% [8%]
EBITDA [adjusted] 733 [737] 641 [666]
Change compared to previous period  14% [11%] 10% [7%]
Earning for the period 277 248
Change compared to previous period  12% 35%
Earnings per share (in €) 2.48 2.21
Change compared to previous period  12% 35%
R&D expenses 510 468
Change compared to previous period 9% 4%
Free Cashflow
from operating activities [adjusted]
145 [166] 29 [106]
Net capital expediture 312 328
Change compared to previous period -5% 10%
     
EBIT margin [adjusted] 7.9% [8.0%] 7.3% [7.8%]
EBITDA margin [adjusted] 14.3% [14.4%] 13.4% [13.9%]
R&D expenses in relation to sales 9.9% 9.8%
Net capital expediture in relation to sales 6.1% 6.9%
     
  28. Feb 18 31. May 17
Net financial debt 250 278
Net financial debt/EBITDA (last 12 months) 0.2x 0.3x
Equity ratio 41.7% 39.5%
Return on equity (last 12 months) 17.1% 17.3%
Number of employees (headcount) 40,064 37,716

 

Further information can be found in the selected financial information and in the further notes.

03/22/2018
 
 

Quarterly figures

in € million 3rd Quarter 
FY 2017/2018
3rd Quarter
FY 2016/2017
Sales 1,678 1,578
Change compared to previous period
[curency- and portfolio adjusted]
6% [9%] 6% [6%]
EBIT [adjusted] 114 [115] 103 [105]
Change compared to previous period 11% [10%] 18% [17%]
EBITDA [adjusted] 228 [229] 203 [205]
Change compared to previous period 13% [12%] 11% [11%]
Earnings for the period 78 74
Change compared to previous period 5% 41%
Earnings per share (in €) 0.70 0.65
Change compared to previous period 7% 38%
R&D expenses 171 157
Change compared to previous period 9% 0%
Free cashflow from
operating activities [adjusted]
72 [75] 29 [32]
Net capital expenditure 99 120
Change compared to previous period -17% 11%
     
EBIT margin [adjusted] 6.8% [6.9%] 6.5% [6.6%]
EBITDA margin 13.6% [13.7%] 12.9% [13.0%]
R&D expenses in relation to sales 10.2% 9.9%
Net capital expediture in relation to sales 5.9% 7.6%

 

03/22/2018
 
 

Sales by business segments

Sales by business segments

As of May 31, 2017

 
 

Regional market coverage

Regional market coverage

As of May 31, 2017

 
 

Employees by regions

Employees by regions

As of May 31, 2017

 
 
 
 
  • icon_druck
  • Youtube
  • linkedin-logo
 
 
 
Financial calendar
2018-07-17Preliminary Annual Results 2017/18
04/17/2018
2018-08-10Annual Results 2017/18
10/02/2017
2018-09-27Results First Quarter 2018/19
04/17/2018
2018-09-28Annual General Meeting 2018
04/17/2018
 
07/28/2016
Contact

Dr. Kerstin Dodel
Investor Relations
Phone: +49 2941 38 1349
Fax: +49 2941 38 477099
Email: investor.relations@hella.com

 
08/30/2017
Stock Chart
 
05/30/2017